Novel treatments for osteoarthritis: an update
- PMID: 30323693
- PMCID: PMC6174890
- DOI: 10.2147/OARRR.S176666
Novel treatments for osteoarthritis: an update
Abstract
Osteoarthritis is the most prevalent chronic joint condition worldwide. The principles of osteoarthritis treatment are to alleviate pain and stiffness as well as maintain function, with current consensus guidelines recommending the use of a combination of conservative measures including physical therapy, analgesia, and surgical interventions such as arthroplasty. In recent years, several pharmacological therapies have emerged as potential alternatives. Although a disease-modifying osteoarthritis drug has yet to be identified, promising results have been reported in recent trials especially with serotonin-norepinephrine reuptake inhibitors, IL-1 antagonists, and antibodies to nerve growth factor. The present review aims to summarize and discuss the latest results of novel treatments for osteoarthritis and potential targets for future research.
Keywords: future therapy; novel treatment; osteoarthritis; review.
Conflict of interest statement
Disclosure The authors report no conflicts of interest in this work.
References
-
- Glyn-Jones S, Palmer AJR, Agricola R, et al. Osteoarthritis. Lancet. 2015;386(9991):376–387. - PubMed
-
- Bijlsma JW, Berenbaum F, Lafeber FP. Osteoarthritis: an update with relevance for clinical practice. Lancet. 2011;377(9783):2115–2126. - PubMed
-
- Towheed TE. Systematic review of therapies for osteoarthritis of the hand. Osteoarthritis Cartilage. 2005;13(6):455–462. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Medical